Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection

Published:2017-01-12 Issue:5 Volume:45 Page:688-700
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Cornberg M.¹^ORCID,Petersen J.²,Schober A.³,Mauss S.⁴,Böker K. H. W.⁵,Link R.⁶,Günther R.⁷,Serfert Y.⁸,Pfeiffer-Vornkahl H.⁹,Manns M. P.¹,Sarrazin C.¹⁰,Hüppe D.¹¹,Berg T.¹²,Niederau C.¹³

Affiliation:

1. Department of Gastroenterology, Hepatology and Endocrinology; Hannover Medical School, Hannover; Germany and German Center for Infection Research (DZIF), Partner-site Hannover-Braunschweig; Germany

2. IFI-Institute for Interdisciplinary Medicine; Hamburg Germany

3. Hepatologische Praxis; Göttingen Germany

4. Center for HIV and Hepatogastroenterology; Duesseldorf Germany

5. Hepatologische Praxis; Hannover Germany

6. MVZ Offenburg; Offenburg Germany

7. Universitätsklinikum Schleswig-Holstein (UKSH); Campus Kiel; Kiel Germany

8. Leberstiftungs-GmbH Deutschland; Hannover Germany

9. e.factum GmbH; Butzbach Germany

10. St.-Josefs-Hospital Wiesbaden and University Hospital Frankfurt; Frankfurt Germany

11. Hepatologische Schwerpunktpraxis Herne; Herne Germany

12. University Hospital Leipzig; Leipzig Germany

13. St. Josef-Hospital Katholisches Klinikum Oberhausen; Oberhausen Germany

Funder

Deutsches Zentrum für Infektionsforschung

AbbVie Deutschland GmbH & Co. KG

Bristol-Myers Squibb GmbH & Co. KGaA

Gilead Sciences GmbH

Janssen-Cilag GmbH

MSD Sharp & Dohme GmbH

Roche Pharma AG

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13925/fullpdf

Reference29 articles.

1. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013;GBD 2013 Mortality and Causes of Death Collaborators;Lancet,2015

2. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;Meer;JAMA,2012

3. Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies;Deterding;Aliment Pharmacol Ther,2015

4. From non-A, non-B hepatitis to hepatitis C virus cure;Pawlotsky;J Hepatol,2015

5. Review article: HCV genotype 3 - the new treatment challenge;Ampuero;Aliment Pharmacol Ther,2014

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virological characterization of treatment failures and retreatment outcomes in patients infected with “unusual” HCV genotype 1 subtypes;Hepatology;2023-04-01

2. Real-World Therapeutic Outcomes of Direct-Acting Antiviral Regimens and Formidable Challenges;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01

3. The curing regimens of HCV: A SWOT analysis;Antiviral Therapy;2022-04

4. Polypharmacology in Clinical Applications: Gastrointestinal Polypharmacology;Polypharmacology;2022

5. The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R);Journal of Viral Hepatitis;2021-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3